These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37782000)

  • 1. Hierarchy of the Components in Spray-Dried, Protein-Excipient Particles Using DNP-Enhanced NMR Spectroscopy.
    Berruyer P; Lindkvist M; Gracin S; Starciuc T; Bertarello A; Busi B; Schantz S; Emsley L
    Mol Pharm; 2023 Nov; 20(11):5682-5689. PubMed ID: 37782000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalable microparticle platform based on a novel shell-forming lipid excipient and its feasibility for respirable delivery of biologics.
    Wang H; Connaughton P; Lachacz K; Carrigy N; Ordoubadi M; Lechuga-Ballesteros D; Vehring R
    Eur J Pharm Biopharm; 2022 Aug; 177():308-322. PubMed ID: 35905804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
    Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
    Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
    Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of hydrophobic amino acids in protecting spray dried trehalose formulations against moisture-induced changes.
    Mah PT; O'Connell P; Focaroli S; Lundy R; O'Mahony TF; Hastedt JE; Gitlin I; Oscarson S; Fahy JV; Healy AM
    Eur J Pharm Biopharm; 2019 Nov; 144():139-153. PubMed ID: 31536784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine enhances the dispersibility of trehalose-containing spray-dried powders on exposure to a high-humidity environment.
    Wang Z; Wang H; Vehring R
    Int J Pharm; 2021 May; 601():120561. PubMed ID: 33811968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
    Keil TWM; Feldmann DP; Costabile G; Zhong Q; da Rocha S; Merkel OM
    Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Lipidic Excipients on the Particle Properties and Aerosol Performance of High Drug Load Spray Dried Particles for Inhalation.
    Shetty N; Hau J; Yanez E; Shur J; Cheng J; Sun CC; Nagapudi K; Narang A
    J Pharm Sci; 2022 Apr; 111(4):1152-1163. PubMed ID: 34506865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucine as an excipient in spray dried powder for inhalation.
    Alhajj N; O'Reilly NJ; Cathcart H
    Drug Discov Today; 2021 Oct; 26(10):2384-2396. PubMed ID: 33872799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT
    Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of storage temperature on the stability of spray dried bacteriophage powders.
    Leung SSY; Parumasivam T; Nguyen A; Gengenbach T; Carter EA; Carrigy NB; Wang H; Vehring R; Finlay WH; Morales S; Britton WJ; Kutter E; Chan HK
    Eur J Pharm Biopharm; 2018 Jun; 127():213-222. PubMed ID: 29486303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trileucine improves aerosol performance and stability of spray-dried powders for inhalation.
    Lechuga-Ballesteros D; Charan C; Stults CL; Stevenson CL; Miller DP; Vehring R; Tep V; Kuo MC
    J Pharm Sci; 2008 Jan; 97(1):287-302. PubMed ID: 17823950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spray dried progesterone formulations for carrier free dry powder inhalation.
    Hibbard T; Mitchell H; Kim Y; Shankland K; Al-Obaidi H
    Eur J Pharm Biopharm; 2023 Aug; 189():264-275. PubMed ID: 37392870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection.
    Chang RY; Wong J; Mathai A; Morales S; Kutter E; Britton W; Li J; Chan HK
    Eur J Pharm Biopharm; 2017 Dec; 121():1-13. PubMed ID: 28890220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1-34) prepared as a dry powder for inhalation.
    Shoyele SA; Sivadas N; Cryan SA
    AAPS PharmSciTech; 2011 Mar; 12(1):304-11. PubMed ID: 21271316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of cyclodextrins in antibody microparticles: potentials for antibody protection in spray drying.
    Ramezani V; Vatanara A; Seyedabadi M; Nabi Meibodi M; Fanaei H
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1103-1111. PubMed ID: 28276783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of a spray-dried inhalable ciprofloxacin-quercetin co-amorphous system.
    Alhajj N; O'Reilly NJ; Cathcart H
    Int J Pharm; 2022 Apr; 618():121657. PubMed ID: 35288220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Storage stability of inhalable phage powders containing lactose at ambient conditions.
    Chang RYK; Wallin M; Kutter E; Morales S; Britton W; Li J; Chan HK
    Int J Pharm; 2019 Apr; 560():11-18. PubMed ID: 30710661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trileucine as a dispersibility enhancer of spray-dried inhalable microparticles.
    Ordoubadi M; Gregson FKA; Wang H; Carrigy NB; Nicholas M; Gracin S; Lechuga-Ballesteros D; Reid JP; Finlay WH; Vehring R
    J Control Release; 2021 Aug; 336():522-536. PubMed ID: 34229002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Characterization of Excipient Enhanced Growth (EEG) Surfactant Powder Formulations for Treating Neonatal Respiratory Distress Syndrome.
    Boc S; Momin MAM; Farkas DR; Longest W; Hindle M
    AAPS PharmSciTech; 2021 Apr; 22(4):136. PubMed ID: 33860409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.